13th International Conference on Biologics and Biosimilars
Elixsys, Inc., USA
Title: Enabling a global collaborative ecosystem in the realm of biopharma
Biography: Himabindu Gaddipati
The current era of rapidly evolving technology, market trends and policy is creating an increasingly fragmented biopharma value chain. End-to-end research or comprehensive development of a life science product which was once accomplished within an institution or organization is now being facilitated by multiple parallel interactions. Integrating diverse technology and expertise between an array of varied stakeholders across organizational and geographical boundaries is now becoming the norm. However, the logistics required to support a streamlined mechanism to facilitate more effective and efficient interaction and breakdown inter-organizational silos is largely deficient. This is especially relevant in the dynamic arena of cancer research and product development which is being accelerated by the utilization of cutting-edge technology. The solution likely lies in creating a niche environment with the required resources that will bring together diverse stakeholders along the biopharma value chain such as Institutions, pharma and biotech companies, foundations and hospitals in a streamlined manner. The participants can leverage complementary skills and knowledge to amalgamate their capabilities towards unified objectives. Towards this vision, our organization has developed a novel online platform, designed to bring together diverse stakeholders across the cancer care continuum. This is an integrative “Virtual Ecosystem” that will connect groups of organizations worldwide to create “interlinked clusters” of concentrated knowledge, expertise and resources. The cloud-based platform enables users to review domain-specific expertise of others and initiate communication with the potential partner(s). The platform is specifically designed to integrate and streamline all activity amongst group members throughout the process of preliminary exploration, sourcing/raising funds, strategic planning and execution of a project. Ultimately this will empower stakeholders along the lifecycle to conduct synchronized initiatives on a global scale. Immense value can be generated by creating such cohesive mechanisms to enhance cost and time efficiency while reducing redundancy.